Topotecan for the treatment of recurrent or progressive central nervous system tumors - a pediatric oncology group phase II study.

R P Kadota; C F Stewart; M Horn; J F Kuttesch; P C Burger; J L Kepner; L E Kun; H S Friedman; R L Heideman

doi:10.1023/a:1006294102611

Topotecan for the treatment of recurrent or progressive central nervous system tumors - a pediatric oncology group phase II study.

Identifier:nobleid.org/w1/20260515/FC8BBAFF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/FC8BBAFF.svg?ark=w1%2F20260515%2FFC8BBAFF)](https://nobleid.org/work/w1/20260515/FC8BBAFF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Topotecan for the treatment of recurrent or progressive central nervous system tumors - a pediatric oncology group phase II study.

Identifier:nobleid.org/w1/20260515/FC8BBAFF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/FC8BBAFF.svg?ark=w1%2F20260515%2FFC8BBAFF)](https://nobleid.org/work/w1/20260515/FC8BBAFF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work